Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-107,781
Closed -$48.7K 2051
2025
Q2
$48.7K Buy
+107,781
New +$46.9K 0.01% 1114
2024
Q3
Sell
-15,105
Closed -$10.1K 3707
2024
Q2
$10.1K Buy
15,105
+4,875
+48% +$4.05K ﹤0.01% 2802
2024
Q1
$13.3K Sell
10,230
-39,175
-79% -$41K ﹤0.01% 2731
2023
Q4
$28.3K Sell
49,405
-24,468
-33% -$16.9K ﹤0.01% 2675
2023
Q3
$55.7K Buy
73,873
+8,042
+12% +$6.12K ﹤0.01% 2460
2023
Q2
$48.1K Buy
+65,831
New +$61.2K ﹤0.01% 2399
2023
Q1
Sell
-22,169
Closed -$21.3K 3332
2022
Q4
$21.3K Buy
22,169
+10,930
+97% +$15.4K ﹤0.01% 2266
2022
Q3
$25K Sell
11,239
-2,316
-17% -$7.99K ﹤0.01% 2274
2022
Q2
$47K Sell
13,555
-2,884
-18% -$10.8K ﹤0.01% 1855
2022
Q1
$83K Buy
+16,439
New +$83.3K ﹤0.01% 1827
2018
Q1
Sell
-1,288
Closed -$8K 2993
2017
Q4
$8K Buy
+1,288
New +$9K ﹤0.01% 1682

Other funds holding VXRT

Two Sigma Securities's VXRT Position: Q3 2025 in Review

Two Sigma Securities sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 107,781 shares — an estimated $48.7K sold.

Two Sigma Securities first reported a position in VXRT in Q4 2017 and held it in 11 quarters. The position peaked at $83K in Q1 2022. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Two Sigma Securities reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 107,781 Vaxart shares in Q3 2025, an estimated $48.7K.
  • Two Sigma Securities first reported a position in Vaxart in Q4 2017 and held it in 11 quarters.
  • Two Sigma Securities's Vaxart position peaked at $83K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.